Digital Health
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The funding will support clinical trials for the company's NeuroHawk brain-scanning device.
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.
The company offers a marketplace for individuals seeking addiction and mental health treatment. It will use the funds to scale its workforce and expand its reach.
The aim is to attract government and healthcare experts who can gain a better understanding of digitalization in healthcare.
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.
The funds will be used to scale partnerships with health plans, employers and community-based public health agencies across the country.
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.